Insights On Drug Development

  1. From iPSCs To Functional NK Cell Therapy - A Client Journey 10/30/2024

    Discover how iPSC-based allogeneic cell therapies, guided by Cellistic's top experts and powered by Pulse and Echo platforms, are set to transform healthcare.

  2. Platform Approach For Identifying The Most Functional And Developable Bispecific T-Cell Engager 10/28/2024

    Explore groundbreaking platforms for designing bispecific antibodies that enhance cancer targeting and immune recruitment, setting new standards in cancer treatment efficacy.

  3. Who Pays When New Equipment Is Needed At Your CDMO? 10/24/2024

    Our panelists have some intriguing thoughts about how to negotiate the purchase of new equipment needed for your program at your CDMO.

  4. Is CDMO Quality A Concern Today? 10/24/2024

    All three of our speakers – Praveen Prasana, Verve Therapeutics; Scott Jeffers, GenSight Biologics; Vaibhav Patel, University of Minnesota – discuss quality concerns at CDMOs.

  5. For ATMP Services, Teach Your CDMO Well 10/24/2024

    It’s great to outsource to the most experienced CDMOs. But your program is indeed novel. How do you close the knowledge gap with your partner? We have some suggestions.

  6. Is Your CDMO's Pricing Acceptable? 10/24/2024

    Is the price for materials and services your CDMO is presenting you a fair price? How can you determine that? A quick discussion on pricing from an experienced outsourcer.

  7. Small Biotech, Large CDMO: Like a Round Peg In A Square Hole? 10/24/2024

    Can smaller biotechs get the service they need from large CDMOs? Three experienced professionals have mixed – and very helpful – feelings and experiences to share.

  8. Scoring Your Tech Transfer 10/24/2024

    Attendees of a recent Outsourced Pharma Live asked our speakers about methods to evaluate (score) tech transfers to CDMOs. Scott Jeffers of GenSight Biologics had some thoughts.

  9. Selecting Your CDMO And Thinking of Quality 10/24/2024

    During our digital event, Selecting & Managing CDMOs For Novel Therapies, our speakers dive into criteria for the selection of CDMOs, with an eye on quality.

  10. A "Mutual" Contract With Your CDMO 10/24/2024

    Some initial thoughts on putting discussions with your CDMO into details in a contract that makes both you and your CDMO want to work together.